PHARMACEUTICAL COMPOSITION
PROBLEM TO BE SOLVED: To provide forms and formulations of VX-950 having improved bioavailability relative to crystalline VX-950.SOLUTION: Amorphous VX-950, for example the VX-950 that is substantially free of impurities and/or crystalline VX-950 is provided. Pharmaceutical formulations containing t...
Gespeichert in:
Hauptverfasser: | , , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | PROBLEM TO BE SOLVED: To provide forms and formulations of VX-950 having improved bioavailability relative to crystalline VX-950.SOLUTION: Amorphous VX-950, for example the VX-950 that is substantially free of impurities and/or crystalline VX-950 is provided. Pharmaceutical formulations containing the VX-950 in the amorphous form used for treating hepatitis C virus are also provided. |
---|